Skip to content

Exercise in the Fasted State, Glucose Metabolism and Energy Balance

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02258399
Enrollment
12
Registered
2014-10-07
Start date
2015-05-31
Completion date
2017-12-31
Last updated
2018-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Energy Balance, Blood Glucose

Brief summary

The ability to control our blood glucose (sugar) concentrations after a meal is a strong predictor of the risk of disease. Our bodies respond to glucose ingestion by reducing the amount of glucose from the liver entering the bloodstream. At the same time muscle increases the amount of glucose it take up from the bloodstream. This ensures that our blood glucose levels do not get too high. The investigators want to understand what happens to these processes following exercise after breakfast and after an overnight fast. In addition, the investigators also want to understand whether exercising with or without breakfast influences our appetite, food intake and activity levels later in the day.

Interventions

BEHAVIORALExercise

Moderate intensity exercise

DIETARY_SUPPLEMENTBreakfast

Breakfast consumption

Sponsors

University of Stirling
CollaboratorOTHER
University of Birmingham
CollaboratorOTHER
University of Bath
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to 49 Years
Healthy volunteers
Yes

Inclusion criteria

* Males. * Aged 18-49. * Individuals free from known cardiovascular, metabolic or joint disease as determined by standard health questionnaire. * Habitual regularly participating in exercise (minimum of 3 sessions per week on average) * Non-smoker

Exclusion criteria

* Known or suspected food intolerances, allergies or hypersensitivity. * Any bleeding disorder or taking medication which impacts blood coagulation. * Known tendency towards keloid scarring. * Known sensitivity or allergy to any local anaesthetic medicines. * Any reported use of substances which may pose undue personal risk to participants or introduce bias into the experiment. * Any other condition or behaviour deemed either to pose undue personal risk to participants or introduce bias into the experiment.

Design outcomes

Primary

MeasureTime frameDescription
Exogenous glucose appearance rate120 minutesExogenous glucose appearance rates following an oral glucose tolerance test (total appearance over 120 minutes).
Energy balance24 hoursEnergy balance (intake minus expenditure) over 24 h from the beginning of the trial

Secondary

MeasureTime frameDescription
Energy intake24 hWeighted energy intake over 24 hours from the beginning of the trial.
Endogenous glucose appearance rates120 minutesEndogenous glucose appearance rates following an oral glucose tolerance test (total appearance over 120 minutes).
Exogenous glucose appearance rates120 minutesExogenous glucose appearance rates following an oral glucose tolerance test (total appearance over 120 minutes).
Energy expenditure24 hEnergy expenditure, derived from indirect calorimetry, acccelerometry and heart rate monitoring.
Glucose clearance rates120 minutesGlucose clearance rates following an oral glucose tolerance test (total clearance over 120 minutes).

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026